ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TERRELL THOMSON M.D.

Internal Medicine

2,613

$196K

77
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $62

JEFFREY HOLVERSON MD

Internal Medicine

1,840

$176K

50
11 are 65+

78%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 11%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

JAHAN IMANI MD

Internal Medicine

1,479

$211K

152
48 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$143
Average prescription price

Avg: $62

ALLISON KIERSTEAD M.D.

Internal Medicine

4,239

$229K

218
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

HUGH STONEBURNER

Internal Medicine

13,855

$754K

457
290 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

GRANT HAWKINS MD

Internal Medicine

14,012

$724K

742
672 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

KEVIN JOHNSON M.D.

Internal Medicine

8,665

$497K

370
320 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $62

THERESA GOURDE MD

Internal Medicine

3,788

$185K

179
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $62

KRISTA SCHONROCK MD

Internal Medicine

11,985

$730K

704
607 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $62

ZANETA BULAJ M.D.

Internal Medicine

7,175

$350K

366
298 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $62

LYNN BATEMAN MD

Internal Medicine

3,954

$206K

288
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

VERE LANCASTER MD

Internal Medicine

7,611

$518K

483
414 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $62

YUN LING MD

Internal Medicine

8,022

$409K

518
428 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

PHILLIP SMITH MD

Internal Medicine

13,705

$1.12M

589
470 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $62

NUPUR AGGARWAL MD

Internal Medicine

7,096

$388K

403
309 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

THOMAS KOTTARATHIL

Internal Medicine

16,558

$916K

706
413 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

DANIEL YARRISH M.D.

Internal Medicine

8,000

$429K

398
343 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

TIMOTHY COSTA MD

Internal Medicine

2,929

$121K

138
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $62

JOHN STAHELI MD

Internal Medicine

3,682

$288K

323
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$78
Average prescription price

Avg: $62

JEFFREY JOHNSON MD

Internal Medicine

9,275

$601K

439
388 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

CLAUDE WARNER MD

Internal Medicine

11,988

$742K

482
431 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $62

REGINA DRUEDING M.D.

Internal Medicine

1,365

$126K

80
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

RICHARD BROWN MD

Internal Medicine

3,174

$158K

324
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $62

CHRISTOPHER JONES MD

Internal Medicine

7,314

$557K

571
478 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $62

J BANE MD

Internal Medicine

10,005

$554K

466
395 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank